Medtech Insight is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CryoLife seeks US clearance for lung-repair patches:

This article was originally published in Clinica

Executive Summary

US firm CryoLife has filed a 510(k) application with the US FDA for clearance to market its BioGlue surgical patch for sealing lung and bronchial tissues during pulmonary procedures. A pre-filled cartridge of the company's BioGlue patch adhesive and a device for delivering the adhesive will be provided together with the patch, said Atlanta, Georgia-based CryoLife. The company's BioGlue surgical adhesive is already available in Europe for vascular and pulmonary repair (see Clinica No 851, p 16).

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT078276

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel